We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




LAMP-Kit Diagnoses Non-Falciparum Malaria

By LabMedica International staff writers
Posted on 26 Jan 2017
Malaria incidence has recently been declining globally, although in many African countries it is still one of the top health problems and the efforts to control and eradicate malaria will still need a strong diagnostic capacity, which allows any parasitaemic patient to be detected and treated sooner.

Loop-mediated isothermal amplification (LAMP) is a simple molecular diagnostic method based on the principle of isothermal amplification, which does not require special equipment or special distribution in laboratories, and provide results in 60 minutes. More...
A LAMP-kit can be used in the field without special equipment and could have an important role in malaria control programs in endemic areas and for malaria diagnosis in returned travelers.

Scientists at the National Center for Microbiology of Majadahonda and their colleagues have determined the diagnostic validity of a LAMP-kit to diagnose Plasmodium ovale and compare it to microscopy and conventional multiplex nested polymerase chain reaction (nPCR) in the diagnosis of P. ovale infections in archived clinical specimens. They also compared the naked eye reading of the amplification products with the automated reading by turbidimetry as well as to determine the specificity of the P. falciparum LoopAmp primer in specimens of patients infected with P. ovale.

Plasmodium ovale positive samples (29, tested by PCR and/or microscopy) and malaria negative specimens (398, tested by microscopy and PCR) were collected in different hospitals of Europe from June 2014 to March 2016. DNA was extracted from all samples and amplification was performed with LoopAMP MALARIA kit in an Eiken 500 automated turbidimeter. The results of LAMP read by turbidimetry and with the naked eye were compared.

The LAMP-kit showed a sensitivity of 100% and a specificity of 97.24% with positive and negative predictive values of 72.5% and 100%, respectively. Naked eyed readings were in accordance with turbidimetry readings (sensitivity, 92.5%, specificity, 98.96% and positive and negative predictive values, respectively, 90.24% and 99.22%). The limit of detection of LAMP assay for P. ovale was between 0.8 and 2 parasites/µL. P. falciparum LAMP reactions were found to be negative in 29 out of 29 confirmed P. ovale samples. The one P. ovale sample positive by P. falciparum LAMP was excluded as it was found to be also positive for P. falciparum by nPCR.

The authors concluded that the Pan primer of the Malaria kit LoopAMP can detect P. ovale at very low-levels and it showed a predictive negative value of 100%. The relative simplicity of the LAMP procedure and the low infrastructure costs open a range of opportunities by bringing molecular-level parasite detection and capacity of using malaria LAMP in field settings. The study was published on January 7, 2017, in the Malaria Journal.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Immunofluorescence Analyzer
IFA System
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.